Skip to Content

F19 25 (Dapsone 25 mg)

Pill with imprint F19 25 is White, Round and has been identified as Dapsone 25 mg. It is supplied by Fera Pharmaceuticals, LLC.

Dapsone is used in the treatment of dermatitis herpetiformis; leprosy, lepromatous; bullous pemphigoid; leprosy; leprosy, tuberculoid (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for F19 25

Dapsone

Imprint:
F19 25
Strength:
25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Leprostatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Fera Pharmaceuticals, LLC
National Drug Code (NDC):
48102-0019

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide